Inhibition of interaction between OCT4 and MAPKAPK2 or DNA-PKcs to regulate c-MYC in cancer
US-12491191-B2 · Dec 9, 2025 · US
This page is not indexed by search engines while we improve data quality.
Glycosides
Glycosides · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07J19/005 |
| Official title | {Glycosides} |
| Display label | Glycosides |
| Total patents | 11 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 1 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Inhibition of interaction between oct4 and mapkapk2 or dna-pkcs to regulate c-myc in cancer
US-2022233554-A1 · Jul 28, 2022 · US
Selective inhibitors of Alpha2-containing isoforms of Na,K-ATPase and use thereof for reduction of intraocular pressure
US-11077128-B2 · Aug 3, 2021 · US
SELECTIVE INHIBITORS OF Alpha2-CONTAINING ISOFORMS OF Na,K-ATPase AND USE THEREOF FOR REDUCTION OF INTRAOCULAR PRESSURE
US-2020297748-A1 · Sep 24, 2020 · US
Selective inhibitors of Alpha2-containing isoforms of Na,K-ATPase and use thereof for reduction of intraocular pressure
US-10668094-B2 · Jun 2, 2020 · US
SELECTIVE INHIBITORS OF Alpha2-CONTAINING ISOFORMS OF Na,K-ATPase AND USE THEREOF FOR REDUCTION OF INTRAOCULAR PRESSURE
US-2018207189-A1 · Jul 26, 2018 · US
Selective inhibitors of α2 isoform of Na,K-ATPase and use thereof for reduction of intra-ocular pressure and as cardiotonic agents
US-9938316-B2 · Apr 10, 2018 · US
Contraceptive agents
US-9670247-B2 · Jun 6, 2017 · US
Steroid compounds as RORyt modulators and uses thereof
US-9505798-B2 · Nov 29, 2016 · US
SELECTIVE INHIBITORS OF ALPHA2 ISOFORM OF Na,K-ATPase AND USE FOR REDUCTION OF INTRA-OCULAR PRESSURE
US-2016244479-A1 · Aug 25, 2016 · US
Glycosylated cardiotonic steroids
US-2016176914-A1 · Jun 23, 2016 · US